Cancer cells often express BCRP at elevated levels, contributing to multidrug resistance (MDR), which poses a significant challenge in cancer treatment. By pumping out chemotherapeutic drugs, BCRP reduces their intracellular concentration, diminishing their efficacy. Understanding BCRP's role in drug resistance is vital for developing strategies to overcome this mechanism and improve cancer treatment outcomes.
